Invention Grant
US08417311B2 Fluid component analysis system and method for glucose monitoring and control
有权
用于葡萄糖监测和控制的流体成分分析系统和方法
- Patent Title: Fluid component analysis system and method for glucose monitoring and control
- Patent Title (中): 用于葡萄糖监测和控制的流体成分分析系统和方法
-
Application No.: US12559328Application Date: 2009-09-14
-
Publication No.: US08417311B2Publication Date: 2013-04-09
- Inventor: Peter Rule
- Applicant: Peter Rule
- Applicant Address: US CA Hayward
- Assignee: Optiscan Biomedical Corporation
- Current Assignee: Optiscan Biomedical Corporation
- Current Assignee Address: US CA Hayward
- Agency: Knobbe Martens Olson & Bear LLP
- Main IPC: A61B5/05
- IPC: A61B5/05

Abstract:
Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e.g. insulin, dextrose, etc.) and provide glycemic control. The dose of the treatment drug may be based on the patient's calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.
Public/Granted literature
- US20100121170A1 FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL Public/Granted day:2010-05-13
Information query